| Pharmaceuticals Industry | Healthcare Sector | Toru Ashida CEO | OTC PINK Exchange | JP3701000006 ISIN |
| DE Country | 987 Employees | 29 Sep 2026 Last Dividend | 30 Sep 2020 Last Split | - IPO Date |
JCR Pharmaceuticals Co., Ltd. is a prominent entity in the pharmaceutical industry, focusing on the research, development, manufacturing, and distribution of pharmaceutical products, regenerative medicines, and drug substances. Founded in 1975 and headquartered in Ashiya, Japan, the company operates both domestically and internationally. It specializes in providing innovative therapeutic solutions across a range of medical conditions. Moreover, JCR Pharmaceuticals actively engages in collaborations and joint research projects to advance novel biologic therapies and gene therapy delivery technologies, specifically targeting Central Nervous System (CNS) diseases. Its commitment to enhancing healthcare and bringing new solutions to market demonstrates its pivotal role in pharmacy and medicine.
In addition to these pharmaceutical products, JCR Pharmaceuticals also engages in the sale, import, and export of medical devices and laboratory instruments. The company's distribution network for medical and research equipment further underscores its holistic approach to addressing healthcare needs, from therapeutic solutions to essential medical infrastructure.